Learning to tame pain: new study tests education program for hemophilia joint pain
NCT ID NCT07420387
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a structured educational program can help adults with hemophilia who have chronic joint pain. The program teaches about pain, emotions, and coping strategies. 70 participants will be randomly assigned to either the education program or usual care, and their pain levels will be tracked for six months.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- structured pain education program
- What this could lead to
- If it works, this could offer a safe, drug-free way to help people with hemophilia manage chronic joint pain and improve their quality of life.
- What could go wrong
- This is a small, early-stage trial with only 70 people. The benefits may be modest or not last long, and results may not apply to everyone with hemophilia.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 70 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Mar 2026
An estimate. Start dates often move.
- Expected to finish
-
Sep 2027
An estimate. End dates often move.
- Lead sponsor
-
A research network
The lead sponsor is a research network or cooperative group.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Male participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adult patients with a confirmed diagnosis of hemophilia A or B. * Presence of hemophilic arthropathy. * Presence of chronic pain. Exclusion Criteria: * Patients with neurological or cognitive impairments that preclude understanding of the educational sessions. * Patients who have undergone surgical intervention within the two months preceding the educational program
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Hemophilia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Universidad de Oviedo
Oviedo, Principality of Asturias, 33006, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a 12-Week exercise programme build strength safely in boys with hemophilia?
- Can a newer clotting factor keep its effectiveness in hemophilia a?
- Can a clotting boost make surgery safer for hemophilia patients?
- A facelift without the bruising? tranexamic acid put to the test.
- Deep gum cleaning may boost quality of life for hemophilia patients
- Can a video call replace the clinic for hemophilia pain relief?